120 related articles for article (PubMed ID: 30483798)
1. Tumor p16INK4 gene expression and prognosis in colorectal cancer.
Kitamura H; Takemura H; Minamoto T
Oncol Rep; 2019 Feb; 41(2):1367-1376. PubMed ID: 30483798
[TBL] [Abstract][Full Text] [Related]
2. Prognostic significance of p16(INK4a) hypermethylation in non-small cell lung cancer is evident by quantitative DNA methylation analysis.
Ota N; Kawakami K; Okuda T; Takehara A; Hiranuma C; Oyama K; Ota Y; Oda M; Watanabe G
Anticancer Res; 2006; 26(5B):3729-32. PubMed ID: 17094392
[TBL] [Abstract][Full Text] [Related]
3. Methylation and expression of p16INK4 tumor suppressor gene in primary colorectal cancer tissues.
Kim BN; Yamamoto H; Ikeda K; Damdinsuren B; Sugita Y; Ngan CY; Fujie Y; Ogawa M; Hata T; Ikeda M; Ohue M; Sekimoto M; Monden T; Matsuura N; Monden M
Int J Oncol; 2005 May; 26(5):1217-26. PubMed ID: 15809712
[TBL] [Abstract][Full Text] [Related]
4. p16INK4a gene promoter hypermethylation in mucosa as a prognostic factor for patients with colorectal cancer.
Wettergren Y; Odin E; Nilsson S; Carlsson G; Gustavsson B
Mol Med; 2008; 14(7-8):412-21. PubMed ID: 18418463
[TBL] [Abstract][Full Text] [Related]
5. Aberrant p16((INK4a)) methylation is a frequent event in colorectal cancers: prognostic value and relation to mRNA expression and immunoreactivity.
Mitomi H; Fukui N; Tanaka N; Kanazawa H; Saito T; Matsuoka T; Yao T
J Cancer Res Clin Oncol; 2010 Feb; 136(2):323-31. PubMed ID: 19779933
[TBL] [Abstract][Full Text] [Related]
6. Impact of catechol-O-methyltransferase gene variants on methylation status of P16 and MGMT genes and their downregulation in colorectal cancer.
Wani HA; Majid S; Bhat AA; Amin S; Farooq R; Bhat SA; Naikoo NA; Beigh MA; Kadla SA
Eur J Cancer Prev; 2019 Mar; 28(2):68-75. PubMed ID: 30379684
[TBL] [Abstract][Full Text] [Related]
7. Methylation profile of promoter region of p16 gene in colorectal cancer patients of Kashmir valley.
Wani HA; Beigh MA; Amin S; Bhat AA; Bhat S; Khan H; Mattoo AA; Showkat M; Masood A; Majid S
J Biol Regul Homeost Agents; 2013; 27(2):297-307. PubMed ID: 23830381
[TBL] [Abstract][Full Text] [Related]
8. Methylation status and expression of human telomerase reverse transcriptase mRNA in relation to hypermethylation of the p16 gene in colorectal cancers as analyzed by bisulfite PCR-SSCP.
Nomoto K; Maekawa M; Sugano K; Ushiama M; Fukayama N; Fujita S; Kakizoe T
Jpn J Clin Oncol; 2002 Jan; 32(1):3-8. PubMed ID: 11932355
[TBL] [Abstract][Full Text] [Related]
9. Influence of methylated p15 and p16 genes on clinicopathological features in colorectal cancer.
Ishiguro A; Takahata T; Saito M; Yoshiya G; Tamura Y; Sasaki M; Munakata A
J Gastroenterol Hepatol; 2006 Aug; 21(8):1334-9. PubMed ID: 16872319
[TBL] [Abstract][Full Text] [Related]
10. The hypermethylation of p16 gene exon 1 and exon 2: potential biomarkers for colorectal cancer and are associated with cancer pathological staging.
Ye X; Mo M; Xu S; Yang Q; Wu M; Zhang J; Chen B; Li J; Zhong Y; Huang Q; Cai C
BMC Cancer; 2018 Oct; 18(1):1023. PubMed ID: 30348132
[TBL] [Abstract][Full Text] [Related]
11. Prognostic significance of CDKN2A (p16) promoter methylation and loss of expression in 902 colorectal cancers: Cohort study and literature review.
Shima K; Nosho K; Baba Y; Cantor M; Meyerhardt JA; Giovannucci EL; Fuchs CS; Ogino S
Int J Cancer; 2011 Mar; 128(5):1080-94. PubMed ID: 20473920
[TBL] [Abstract][Full Text] [Related]
12. Comethylation of p16 and MGMT genes in colorectal carcinoma: correlation with clinicopathological features and prognostic value.
Krtolica K; Krajnovic M; Usaj-Knezevic S; Babic D; Jovanovic D; Dimitrijevic B
World J Gastroenterol; 2007 Feb; 13(8):1187-94. PubMed ID: 17451198
[TBL] [Abstract][Full Text] [Related]
13. p16 Hypermethylation and KRAS Mutation Are Independent Predictors of Cetuximab Plus FOLFIRI Chemotherapy in Patients with Metastatic Colorectal Cancer.
Kim SH; Park KH; Shin SJ; Lee KY; Kim TI; Kim NK; Rha SY; Roh JK; Ahn JB
Cancer Res Treat; 2016 Jan; 48(1):208-15. PubMed ID: 25943321
[TBL] [Abstract][Full Text] [Related]
14. Aberrant methylation of the p16 gene is frequently detected in advanced colorectal cancer.
Goto T; Mizukami H; Shirahata A; Sakata M; Saito M; Ishibashi K; Kigawa G; Nemoto H; Sanada Y; Hibi K
Anticancer Res; 2009 Jan; 29(1):275-7. PubMed ID: 19331161
[TBL] [Abstract][Full Text] [Related]
15. Hypermethylation of the MYOD1 gene is a novel prognostic factor in patients with colorectal cancer.
Hiranuma C; Kawakami K; Oyama K; Ota N; Omura K; Watanabe G
Int J Mol Med; 2004 Mar; 13(3):413-7. PubMed ID: 14767572
[TBL] [Abstract][Full Text] [Related]
16. Hypermethylation and decreased expression of TMEM240 are potential early-onset biomarkers for colorectal cancer detection, poor prognosis, and early recurrence prediction.
Chang SC; Liew PL; Ansar M; Lin SY; Wang SC; Hung CS; Chen JY; Jain S; Lin RK
Clin Epigenetics; 2020 May; 12(1):67. PubMed ID: 32398064
[TBL] [Abstract][Full Text] [Related]
17. K-ras and p16 aberrations confer poor prognosis in human colorectal cancer.
Esteller M; González S; Risques RA; Marcuello E; Mangues R; Germà JR; Herman JG; Capellà G; Peinado MA
J Clin Oncol; 2001 Jan; 19(2):299-304. PubMed ID: 11208819
[TBL] [Abstract][Full Text] [Related]
18. KRAS, BRAF oncogene mutations and tissue specific promoter hypermethylation of tumor suppressor SFRP2, DAPK1, MGMT, HIC1 and p16 genes in colorectal cancer patients.
Bagci B; Sari M; Karadayi K; Turan M; Ozdemir O; Bagci G
Cancer Biomark; 2016 Jun; 17(2):133-43. PubMed ID: 27540971
[TBL] [Abstract][Full Text] [Related]
19. Prognostic value of p16 promoter hypermethylation in colorectal cancer: a meta-analysis.
Jiang W; Wang PG; Zhan Y; Zhang D
Cancer Invest; 2014 Feb; 32(2):43-52. PubMed ID: 24410593
[TBL] [Abstract][Full Text] [Related]
20. p16 gene methylation in colorectal cancers associated with Duke's staging.
Yi J; Wang ZW; Cang H; Chen YY; Zhao R; Yu BM; Tang XM
World J Gastroenterol; 2001 Oct; 7(5):722-5. PubMed ID: 11819863
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
